Skip to main content
ENDO 2026 Main banner

Madhura Tamhankar, MD

Professor of Ophthalmology and Neurology
Scheie Eye Institute, University of Pennsylvania
Philadelphia, PA, United States

Madhura Tamhankar, MD is a board-certified neuro-ophthalmologist and strabismus surgeon, serving as an Professor of Ophthalmology and Neurology at the Scheie Eye Institute, University of Pennsylvania, where she has been a faculty member since 2007. A leader in both clinical care and research, Dr. Tamhankar specializes in thyroid eye disease (TED) and early diagnosis of giant cell arteritis (GCA).
In 2018, she founded the region’s only comprehensive TED Program in collaboration with oculoplastics, offering multidisciplinary care and serving as a hub for national referrals. She leads several clinical trials evaluating innovative therapies, including Teprotumumab, Satralizumab, Efgartigimod, and novel agents from Viridian Therapeutics. She serves as a national advisor to companies including Amgen, Genentech, Argenx, and Viridian, and is analyzing real-world data from the IRIS Registry to better understand TED’s natural history and treatment outcomes.
Dr. Tamhankar holds key leadership positions, including Chair of the Neuro-Ophthalmology Society at the American Academy of Ophthalmology (AAO) and examiner for the American Board of Ophthalmology. She also contributes to national competency standards by authoring educational content and organizing major symposia.
Her career is driven by a commitment to advancing clinical trials, improving diagnostics, mentoring future leaders, and shaping national policies in ophthalmology.

Disclosure information not submitted.

Presentation(s):